Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death

Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

Lluis Mont, Antonio Pelliccia, Sanjay Sharma, Alessandro Biffi, Mats Borjesson, Josep Brugada Terradellas, Francois Carre, Eduard Guasch, Hein Heidbuchel, Andre La Gerche, Rachel Lampert, William McKenna, Michail Papadakis, Silvia G. Priori, Mauricio Scanavacca, Paul Thompson, Christian Sticherling, Sami Viskin, Mathew Wilson, Domenico Corrado & 18 others Lip Y.H. Gregory, Bulent Gorenek, Carina Blomström Lundqvist, Bela Merkely, Gerhard Hindricks, Antonio Hernandez-Madrid, Deirdre Lane, Guiseppe Boriani, Calambur Narasimhan, Manlio F. Marquez, David Haines, Judith Mackall, Pedro Manuel Marques-Vidal, Ugo Corra, Martin Halle, Monica Tiberi, Josef Niebauer, Massimo Piepoli

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Sudden cardiac death (SCD) associated with athletic activity is a rare but devastating event. Victims are usually young and apparently healthy, and while many of these deaths remain unexplained, a substantial number of victims harbour an underlying and potentially detectable cardiovascular (CV) disease.1–4 The vast majority of these events are due to malignant tachyarrhythmias, usually ventricular fibrillation (VF) or ventricular tachycardia (VT) degenerating into ventricular fibrillation (VF), occurring in individuals with arrhythmogenic disorders (e.g. hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, channelopathies). Intensive exercise training and competitive sport participation is a trigger that may favour insurgence of ominous ventricular tachyarrhythmias in predisposed individuals.5 Consequently, there is a great interest in early identification of at-risk individuals for whom appropriate treatment, followed or not by physical activity adjustment, may be implemented to minimize the risk of SCD. However, the role of pre-participation evaluation (PPE) in athletes as a feasible and efficient strategy to identify individuals at risk has remained controversial.
Original languageEnglish
Pages (from-to)139-163
Number of pages25
JournalEuropace
Volume19
Issue number1
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Sudden Death
Sports
Sudden Cardiac Death
Ventricular Fibrillation
Tachycardia
Channelopathies
Exercise
Hypertrophic Cardiomyopathy
Ventricular Tachycardia
Cardiomyopathies
Athletes
Therapeutics

Cite this

Mont, Lluis ; Pelliccia, Antonio ; Sharma, Sanjay ; Biffi, Alessandro ; Borjesson, Mats ; Terradellas, Josep Brugada ; Carre, Francois ; Guasch, Eduard ; Heidbuchel, Hein ; La Gerche, Andre ; Lampert, Rachel ; McKenna, William ; Papadakis, Michail ; Priori, Silvia G. ; Scanavacca, Mauricio ; Thompson, Paul ; Sticherling, Christian ; Viskin, Sami ; Wilson, Mathew ; Corrado, Domenico ; Gregory, Lip Y.H. ; Gorenek, Bulent ; Lundqvist, Carina Blomström ; Merkely, Bela ; Hindricks, Gerhard ; Hernandez-Madrid, Antonio ; Lane, Deirdre ; Boriani, Guiseppe ; Narasimhan, Calambur ; Marquez, Manlio F. ; Haines, David ; Mackall, Judith ; Marques-Vidal, Pedro Manuel ; Corra, Ugo ; Halle, Martin ; Tiberi, Monica ; Niebauer, Josef ; Piepoli, Massimo. / Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death : Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. In: Europace. 2017 ; Vol. 19, No. 1. pp. 139-163.
@article{8afde7cefe634537b110849da3654390,
title = "Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE",
abstract = "Sudden cardiac death (SCD) associated with athletic activity is a rare but devastating event. Victims are usually young and apparently healthy, and while many of these deaths remain unexplained, a substantial number of victims harbour an underlying and potentially detectable cardiovascular (CV) disease.1–4 The vast majority of these events are due to malignant tachyarrhythmias, usually ventricular fibrillation (VF) or ventricular tachycardia (VT) degenerating into ventricular fibrillation (VF), occurring in individuals with arrhythmogenic disorders (e.g. hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, channelopathies). Intensive exercise training and competitive sport participation is a trigger that may favour insurgence of ominous ventricular tachyarrhythmias in predisposed individuals.5 Consequently, there is a great interest in early identification of at-risk individuals for whom appropriate treatment, followed or not by physical activity adjustment, may be implemented to minimize the risk of SCD. However, the role of pre-participation evaluation (PPE) in athletes as a feasible and efficient strategy to identify individuals at risk has remained controversial.",
author = "Lluis Mont and Antonio Pelliccia and Sanjay Sharma and Alessandro Biffi and Mats Borjesson and Terradellas, {Josep Brugada} and Francois Carre and Eduard Guasch and Hein Heidbuchel and {La Gerche}, Andre and Rachel Lampert and William McKenna and Michail Papadakis and Priori, {Silvia G.} and Mauricio Scanavacca and Paul Thompson and Christian Sticherling and Sami Viskin and Mathew Wilson and Domenico Corrado and Gregory, {Lip Y.H.} and Bulent Gorenek and Lundqvist, {Carina Blomstr{\"o}m} and Bela Merkely and Gerhard Hindricks and Antonio Hernandez-Madrid and Deirdre Lane and Guiseppe Boriani and Calambur Narasimhan and Marquez, {Manlio F.} and David Haines and Judith Mackall and Marques-Vidal, {Pedro Manuel} and Ugo Corra and Martin Halle and Monica Tiberi and Josef Niebauer and Massimo Piepoli",
year = "2017",
doi = "10.1093/europace/euw243",
language = "English",
volume = "19",
pages = "139--163",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "1",

}

Mont, L, Pelliccia, A, Sharma, S, Biffi, A, Borjesson, M, Terradellas, JB, Carre, F, Guasch, E, Heidbuchel, H, La Gerche, A, Lampert, R, McKenna, W, Papadakis, M, Priori, SG, Scanavacca, M, Thompson, P, Sticherling, C, Viskin, S, Wilson, M, Corrado, D, Gregory, LYH, Gorenek, B, Lundqvist, CB, Merkely, B, Hindricks, G, Hernandez-Madrid, A, Lane, D, Boriani, G, Narasimhan, C, Marquez, MF, Haines, D, Mackall, J, Marques-Vidal, PM, Corra, U, Halle, M, Tiberi, M, Niebauer, J & Piepoli, M 2017, 'Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE', Europace, vol. 19, no. 1, pp. 139-163. https://doi.org/10.1093/europace/euw243

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death : Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. / Mont, Lluis; Pelliccia, Antonio; Sharma, Sanjay; Biffi, Alessandro; Borjesson, Mats; Terradellas, Josep Brugada; Carre, Francois; Guasch, Eduard; Heidbuchel, Hein; La Gerche, Andre; Lampert, Rachel; McKenna, William; Papadakis, Michail; Priori, Silvia G.; Scanavacca, Mauricio; Thompson, Paul; Sticherling, Christian; Viskin, Sami; Wilson, Mathew; Corrado, Domenico; Gregory, Lip Y.H.; Gorenek, Bulent; Lundqvist, Carina Blomström; Merkely, Bela; Hindricks, Gerhard; Hernandez-Madrid, Antonio; Lane, Deirdre; Boriani, Guiseppe; Narasimhan, Calambur; Marquez, Manlio F.; Haines, David; Mackall, Judith; Marques-Vidal, Pedro Manuel; Corra, Ugo; Halle, Martin; Tiberi, Monica; Niebauer, Josef; Piepoli, Massimo.

In: Europace, Vol. 19, No. 1, 2017, p. 139-163.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death

T2 - Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

AU - Mont, Lluis

AU - Pelliccia, Antonio

AU - Sharma, Sanjay

AU - Biffi, Alessandro

AU - Borjesson, Mats

AU - Terradellas, Josep Brugada

AU - Carre, Francois

AU - Guasch, Eduard

AU - Heidbuchel, Hein

AU - La Gerche, Andre

AU - Lampert, Rachel

AU - McKenna, William

AU - Papadakis, Michail

AU - Priori, Silvia G.

AU - Scanavacca, Mauricio

AU - Thompson, Paul

AU - Sticherling, Christian

AU - Viskin, Sami

AU - Wilson, Mathew

AU - Corrado, Domenico

AU - Gregory, Lip Y.H.

AU - Gorenek, Bulent

AU - Lundqvist, Carina Blomström

AU - Merkely, Bela

AU - Hindricks, Gerhard

AU - Hernandez-Madrid, Antonio

AU - Lane, Deirdre

AU - Boriani, Guiseppe

AU - Narasimhan, Calambur

AU - Marquez, Manlio F.

AU - Haines, David

AU - Mackall, Judith

AU - Marques-Vidal, Pedro Manuel

AU - Corra, Ugo

AU - Halle, Martin

AU - Tiberi, Monica

AU - Niebauer, Josef

AU - Piepoli, Massimo

PY - 2017

Y1 - 2017

N2 - Sudden cardiac death (SCD) associated with athletic activity is a rare but devastating event. Victims are usually young and apparently healthy, and while many of these deaths remain unexplained, a substantial number of victims harbour an underlying and potentially detectable cardiovascular (CV) disease.1–4 The vast majority of these events are due to malignant tachyarrhythmias, usually ventricular fibrillation (VF) or ventricular tachycardia (VT) degenerating into ventricular fibrillation (VF), occurring in individuals with arrhythmogenic disorders (e.g. hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, channelopathies). Intensive exercise training and competitive sport participation is a trigger that may favour insurgence of ominous ventricular tachyarrhythmias in predisposed individuals.5 Consequently, there is a great interest in early identification of at-risk individuals for whom appropriate treatment, followed or not by physical activity adjustment, may be implemented to minimize the risk of SCD. However, the role of pre-participation evaluation (PPE) in athletes as a feasible and efficient strategy to identify individuals at risk has remained controversial.

AB - Sudden cardiac death (SCD) associated with athletic activity is a rare but devastating event. Victims are usually young and apparently healthy, and while many of these deaths remain unexplained, a substantial number of victims harbour an underlying and potentially detectable cardiovascular (CV) disease.1–4 The vast majority of these events are due to malignant tachyarrhythmias, usually ventricular fibrillation (VF) or ventricular tachycardia (VT) degenerating into ventricular fibrillation (VF), occurring in individuals with arrhythmogenic disorders (e.g. hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, channelopathies). Intensive exercise training and competitive sport participation is a trigger that may favour insurgence of ominous ventricular tachyarrhythmias in predisposed individuals.5 Consequently, there is a great interest in early identification of at-risk individuals for whom appropriate treatment, followed or not by physical activity adjustment, may be implemented to minimize the risk of SCD. However, the role of pre-participation evaluation (PPE) in athletes as a feasible and efficient strategy to identify individuals at risk has remained controversial.

UR - http://www.scopus.com/inward/record.url?scp=85016169987&partnerID=8YFLogxK

U2 - 10.1093/europace/euw243

DO - 10.1093/europace/euw243

M3 - Article

VL - 19

SP - 139

EP - 163

JO - Europace

JF - Europace

SN - 1099-5129

IS - 1

ER -